Business Context and Reporting Period
This Form 8-K is a current report filed by Mind Medicine (MindMed) Inc. on March 24, 2022. The filing addresses corporate governance changes, specifically the departure of a director and the Chief Financial Officer, as well as executive compensation adjustments. The company is incorporated in British Columbia, Canada, and its securities trade on The Nasdaq Stock Market LLC under the symbol MNMD.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on personnel changes and executive compensation details.
Material Changes and Personnel Actions
- Director Departure: Sarah Y. Vinson, M.D., notified the Board on March 24, 2022, that she will not stand for re-election at the 2022 Annual Meeting. She will serve until immediately prior to the meeting. The Board resolved to reduce its size from six to five members effective at the Annual Meeting. Dr. Vinson stated her decision was not due to any disagreement with the Company.
- CFO Separation: David D. Guebert, Chief Financial Officer, agreed to a separation with the Company on March 25, 2022, with his last day of employment set for March 31, 2022. The separation was not related to any disagreements regarding operations, policies, financial disclosures, or accounting matters.
Executive Compensation and Outlook
The Board approved increases to base salaries effective April 1, 2022, along with cash bonuses for fiscal year 2021 and new equity awards for named executive officers.
| Executive | 2021 Cash Bonus ($) | 2021 Other Payments ($) | 2022 Base Salary ($) | 2022 Options | 2022 RSUs |
|---|---|---|---|---|---|
| Robert Barrow (CEO) | 233,411 | 154,082 | 565,000 | 2,910,000 | 1,820,000 |
| Miri Halperin Wernli (Exec. President) | 175,000 | 50,000 | 390,000 | 780,000 | 600,000 |
| Dr. Daniel R. Karlin (CMO) | 175,000 | 75,000 | 425,000 | 1,250,000 | 950,000 |
| Cynthia Hu (CLO) | 10,400 | — | 390,000 | 1,560,000 | 1,200,000 |
2022 Incentive Bonus Targets: The Board approved target performance bonus percentages for fiscal year 2022 as follows: CEO (50%), Executive President (40%), CMO (40%), and CLO (40%).
Investor Verification Checklist
- Verify the appointment of a new Chief Financial Officer to replace David D. Guebert.
- Confirm the timeline and process for the Board's reduction in size and the election of new directors at the 2022 Annual Meeting.
- Review the vesting schedules for the newly granted options and restricted stock units (RSUs) detailed in the footnotes of the compensation table.
- Check for any subsequent press releases regarding the CFO transition or operational impacts.